About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 283 record(s)
Req # A-2020-18732
A detailed summary of the PMPRB's use of the excessive price penalty on pharmaceutical companies from June 1, 2019 to November 26, 2020. For each penalty, break it down by date, company charged, drug in question, and fine levied.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A 2020_0002
Hand written notes, emails and minutes of the June 2019 CDEV Board meeting approving $12.6 billion construction costs for the Trans Mountain expansion referred to in Q3 2019 Interim Report.Organization: Canada Development Investment Corporation
November 2020
Nothing to report this month
Organization: Canada Development Investment Corporation
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A 2019_0006
Copies of written reports and financial information sent to the head of CDEV and/or to the Minister of Finance between Jan. 1, 2019 and Sept. 11, 2019, related to Canada TMP Finance Limited and/or Trans Mountain Corporation. Please exclude likely cabinet confidences. Exclude HR policies, board controls and reports that have already been made public.Organization: Canada Development Investment Corporation
October 2020
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A 2020_0005
A copy of the Memorandum of Understanding between CDEV and the Department of Natural Resources Canada regarding the Net Profit Interest and Incidental Net Profits Interest (NPI) related to the Hibernia oil project.Organization: Canada Development Investment Corporation
September 2020
Req # A-2020-00004
List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-04135
Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020